The extracellular matrix (ECM) maintenance is crucial to the structural integrity of adipocytes and whole adipose tissue formation. However, the potential impact of the ECM on adipocyte lineage commitment is unclear. Herein, we demonstrate that forced expression of matrix-associated metalloproteinase Adamts1 (a disintegrin and metalloproteinase with thrombospondin motifs 1), which we show is targeted by microRNA-181d (miR-181d) during BMP4-induced adipocytic lineage commitment, markedly impairs adipocyte commitment. Conversely, siRNA-induced inhibition of Adamts1 promotes adipocyte commitment. Adamst1 metalloprotease activity is required for this inhibition and is determined to function via remodeling ECM components followed by activating FAK-ERK signaling pathway during the commitment process. Furthermore, ablation of Adamts1 in adipose tissue increases adipose tissue mass, reduces insulin sensitivity, and disrupts lipid homeostasis. This finding is consistent with Adamts1 decreased expression in the adipose tissue of obese mice and an inverse correlation of Adamts1 expression with body mass index in humans. Collectively, our results indicate that Adamts1 acts as an ECM 'modifier', with miR-181d-induced downregulation, that regulates adipocyte lineage commitment and obesity.
Obesity is characterized by adipose mass expansion through adipocyte hypertrophy and hyperplasia, followed by localized angiogenesis, inflammatory cell infiltration, and extracellular matrix (ECM) remodeling. [1] [2] [3] The protein composition and dynamics of the ECM are of crucial importance to adipocyte function. 4 Among the ECM proteins, collagens are the most abundant protein constituents of interstitial fibers and pericellular basement membranes. 5 Recent reports suggest that obese individuals display excess collagen deposition in adipose tissues. 6, 7 Thbs1, another important ECM protein, has been characterized as an adipokine that is highly expressed in obese subjects. 8 Loss of Thbs1 expression attenuated weight gain and fat accumulation in high-fat diet (HFD) mice. 9 Fibronectin is also abundant in mature adipose tissue. 10 Moreover, other matrix components such as SPARC, osteopontin, decorin, and tenascin C increase significantly in white adipose tissue of obesity individuals. [11] [12] [13] These reports suggest that common ECM molecules provide a critical microenvironment that may impact adipocyte bioactivity and interaction with other cell types. However, few molecular mechanisms for ECM protein regulation of adipogenesis have been defined.
As ECM function depends on its molecular composition, it is important to establish which proteins have been identified as ECM modifiers in adipose tissue. In fact, ECM remodeling requires a balance between constructive and destructive enzymes together with their enhancers and inhibitors. 4 Proteolytic matrix metalloproteases (MMPs) that degrade ECM and basement membrane components are required for adipose tissue development. 14, 15 However, unlike MMPs, the presence and function of the protein Adamts (a disintegrin and metalloproteinase with thrombospondin motifs) in adipose tissue are not fully recognized.
The metalloprotease Adamts1 is characterized by three thrombospondin (TSP)-like domains located at its C terminus. This member of the Adamts extracellular proteases is involved in the processing of procollagen I, procollagen III, and proteoglycans. 16, 17 Adamts1 is synthesized as a p 110 pro-zymogen form that undergoes N-linked glycosylation following protein translation followed by furin enzymatic cleavage to release a p 87 active form. The p 87 active protease can subsequently undergo a secondary processing event to release a p 65 active form that cleaves the last two TSP repeats mediated by MMP2, 8, and 15. 18 In general, Adamts1 has two types of biological functions based on its structure: the metalloproteasedependent catalytic degradation of ECM components, such as cleavage of Thbs1, aggrecan, versican, syndecan-4, semaphorin 3C, and type I collagen; [19] [20] [21] [22] [23] and non-catalytic, TSPdependent angiogenesis inhibition. 24, 25 Of note, Adamts1 may also have other functions related to the inflammatory response. 26 Adamts1 has been implicated in organogenesis, embryogenesis, wound repair, cancer development, and liver fibrosis. [27] [28] [29] [30] However, the specific roles of Adamts1 in adipogenesis, which include mesenchymal stem cell (MSC) lineage commitment and their terminal differentiation into adipocytes, remain undefined. Here, we demonstrate that Adamts1 has a crucial role in adipocyte lineage commitment via ECM-dependent FAK-ERK signaling pathway. Furthermore, we show that Adamts1 knockdown in adipose tissue increases adipose tissue mass, reduces insulin sensitivity and disrupts lipid homeostasis. These observations are in agreement with the findings of decreased Adamts1 expression in the adipose tissue of obese mice and an inverse correlation of Adamts1 expression with body mass index (BMI) in humans.
Results
Obesity reduces the accumulation of Adamts1 in adipose tissue. To gain insight into Adamts1 biological activity, we first examined its expression profile in a wide range of tissues of C57BL/6J mice. As shown in Figure 1a , Adamts1 was highly expressed in inguinal and epididymal white adipose tissue (iWAT and eWAT), suggesting the involvement of Adamts1 in adipogenesis. We then evaluated ADAMTS1 expression in human adipose tissues. As shown in Figures 1b and c, Adamts1 mRNA expression in both subcutaneous and visceral white adipose tissues was inversely correlated with BMI. Parallel results in mice adipose tissues revealed that Adamts1 was markedly downregulated in ob/ob, db/db, and HFD-fed mice as compared with controls (Figures 1d and e) . These results suggested that reduced expression of Adamts1 was indispensable to the development of obesity. It should also be noted that the most abundant Adamts1 protein form in adipose tissue was p 65 (Supplementary Figure S1) , so only the results for the p 65 form are presented for the following experiment. We next isolated the stromal vascular fraction (SVF) and mature adipocytes from the adipose tissue of both HFD-fed and normal chow-fed mice to determine the Adamts1 mRNA expression profile. Results showed that Adamts1 expression in both SVF and mature adipocytes was decreased in iWAT and eWAT from C57BL/6J mice on a HFD as compared with controls ( Figure 1f ). However, Adamts1 exhibited relatively higher transcription levels in SVF compared with the mature adipocyte, suggesting that Adamts1 might have a pivotal role in the process of MSC commitment to form preadipocytes.
Adamts1 impairs BMP4-induced adipocyte lineage commitment. As described previously, 31 BMP4 induces nearly complete commitment of C3H10T1/2 cells to the adipocyte lineage. We next detected Adamts1 expression during BMP4-induced commitment of C3H10T1/2 cells (Supplementary Figure S2A) . The results revealed that Adamts1 is negatively regulated by BMP4 treatment in a dose-dependent manner (Figures 2a and b; Supplementary  Figure S2B) . A more detailed trend in the change is illustrated in Figure 2c , with Adamts1 showing continuously lower protein expression under BMP4 treatment compared with controls. Adamts1 mRNA was maintained at a stable lower level in the BMP4-treated group, while it was continuously raised in controls (Figure 2d ). The impact of BMP4 on Adamts1 was also confirmed in adipose tissue-specific BMP4 transgenic mice. 32 Adamts1 expression was significantly decreased in adipose tissue from BMP4 transgenic mice compared with genetically matched wild-type controls (Figures 2e and f; Supplementary Figure S2C ). These results further confirmed that BMP4 could downregulate the expression of Adamts1. To characterize the function of Adamts1 in adipocyte lineage commitment, we first conducted an RNA interference experiment using specific siRNA to knockdown Adamts1 expression. Adamts1 expression was significantly reduced in both BMP4-treated cells and control cells as Adamts1 protease activity is required to impair adipocyte lineage commitment. The Adamts1 metalloproteinase catalytic site of the zinc-binding peptidase (HEXXHXXXXXHD) was conserved across various species (Figure 3a) . Therefore, a point mutation E403Q, in which the essential Glu residue was converted to Gln, was introduced into the Adamts1 metalloproteinase catalytic domain to underscore the enzyme's role in regulating the adipocyte lineage commitment (Figure 3b) . Inhibition of Pref1 expression by Adamts1 was reversed by this metalloproteinase mutation (Figure 3c ). In addition, adipogenesis was also restored (Figures 3d and e; Supplementary Figure S3A and B). To explore Adamts1 substrates impacting adipocyte lineage commitment, expression of the ECM proteins Thbs1, Fibronectin, and collagens 5, [8] [9] [10] were evaluated. These molecules were downregulated by Adamts1 overexpression with/out BMP4, but not by Adamts1 enzyme inactivation (Figure 3f ). In contrast, Adamts1 silencing increased their expression in the presence of BMP4 (Figure 3g ). As a read-out of Adamts1 expression changes, the expression of Col5α1, Col1α1, and Thbs1 were evaluated in adipose tissues from mice and human. As shown in Supplementary Figure S3C -I, these molecules were upregulated in adipose tissue of HFD and ob/ob mice as compared with control mice. Similarly, mRNA level of these molecules in both subcutaneous and visceral adipose tissues were positively correlated with BMI, which suggesting an inverse correlation between these factors and Adamts1.
FAK-ERK1/2 involves in Adamts1-mediated impairment of adipocyte lineage commitment. To elucidate the mechanism underlying Adamts1-mediated impairment of adipocyte lineage commitment, the activity of potential signaling pathways was evaluated. It has been reported that the p38/ Smad signaling pathway is required for adipocyte lineage commitment. 33 Thus, we wondered whether Adamts1 might influence the p38/Smad signaling pathway. However, no obvious change was observed with overexpressing or silencing Adamts1 (Figures 4a and b) . We next investigated the extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathway, which mediates the function of a variety of ECM proteins through integrin receptor signaling. 34 As illustrated in Figure 4a , overexpression of wild-type Adamts1 activated ERK1/2 signaling, while inactivated Adamts1 had no effect. Conversely, Adamts1 scilencing markedly decreased ERK1/2 phosphorylation with/without BMP4 treatment (Figure 4b ). It has been reported that association of focal adhesion kinase (FAK) with Src leads to activation of ERK via the Grb2-Sos-Ras pathway. 35, 36 We hypothesized that FAK signaling pathways may provide a link between activation of ERK1/2 and ECM. As expected, overexpression of wild-type but not inactivated Adamts1 enhanced FAK phosphorylation level, while Adamts1 scilencing induced the opposite effect in C57BL/6J mice, while recombinant adenovirus expressing LacZ shRNA was injected into the contralateral site as a control. The adeno-Adamts1-shRNA injection significantly decreased adipose Adamts1 mRNA and protein expression compared with the contralateral control (Figures 5a and b ). An expansion of iWAT was observed by Adamts1 silencing (Figures 5c and d) . The size of fat cells can be directly observed in hematoxylin and eosin (H&E) staining (Figure 5e ) and be quantified by using Image J software (Figure 5f ). By this way, enlargement of fat cell was observed with Adamts1 knockdown compared with the paired contralateral LacZ shRNA control (Figures 5c-f) , suggesting enhanced adipogenesis by Adamts1 silencing. To further determine the impact of Adamts1 scilencing on whole-body metabolism, mice were subcutaneously injected with adeno-Adamts1 shRNA adjacent to both inguinal fat pad sites and control mice were bilaterally injected with adeno-LacZ shRNA. Both groups were fed with normal chow diet or HFD, but group body weights diverged following adenovirus injection, with the Adamts1 knockdown mice gaining more weight than the shLacZ control mice (Figure 5g) . Accordingly, the inguinal fat pads with Adamts1 knockdown showed obvious enlargement, but no difference was observed in the epididymal and interscapular fat pads or the liver (Supplementary Figure  S5A-C) . In addition, mice bilaterally injected with adenoAdamts1 shRNA exhibited higher fasting and random serum glucose than control mice (Figure 5h ). Impaired insulin sensitivity and glucose tolerance were also observed in mice bilaterally injected with adeno-Adamts1-shRNA (Figures 5i  and j) . Moreover, lipid metabolism was also disrupted in mice with Adamts1 scilencing, as shown by elevations in plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) (Figure 5k ). These results indicated that disruption of Adamts1 expression in iWAT increased adipose tissue mass and impaired obesity-related metabolic homeostasis such as glucose and lipid metabolism.
MiR-181d was identified as a putative upstream regulator of Adamts1. We next sought to elucidate the mechanism of Adamts1 regulation. Previous studies showed that the 3ʹ-UTR of Adamts1 affects its mRNA stability. 37 As Adamts1 protein levels did not match its mRNA levels over the course of adipocyte lineage commitment (Figures 2c and d) , we assessed possibility that Adamts1 was regulated by microRNAs. Computational prediction of microRNAs targeting Adamts1 was performed using the DIANA MICROT, MIRNA.ORG, and miRDB databases, and microRNA-181d (miR-181d) was identified as a putative upstream regulator of Adamts1 across these three algorithms (Supplementary Figure S6A) . Sequence analysis revealed that the 3ʹ-UTR of Adamts1 from various species was broadly conserved and that two putative binding sites within its 3ʹ-UTR matched the seed sequence of miR-181d (Supplementary Figure S6A and B). To experimentally validate this potential target, the putative miR-181d-binding site and a mutated Adamts1 3ʹ-UTR were, respectively, cloned into the psiCHECK2 vector and co-transfected with the miR-181d mimic or a negative control (Figure 6a ). The miR-181d mimic significantly decreased wild-type Adamts1 3ʹ-UTR luciferase activity, but had a minimal effect on the mutated Adamts1 3ʹ-UTR reporter luciferase activity (Figure 6b ). In addition, Adamts1 expression was inversely correlated with miR-181d expression in subcutaneous and visceral adipose tissues from human with different BMI and mice of HFD, ob/ob, and BMP4-TG (Figures 6c-g ). Upregulation of miR-181d was also observed during the BMP4-treated adipocyte lineage commitment of C3H10T1/2 cells with reduced Adamts1 expression (Figure 6h; Figures 2a-d; Supplementary Figure S6C) . Then, we sought to explore whether a direct link exist between BMP4 and miR-181d expression. Our previous study reported that BMP/Smad signaling pathway has a dominant role in adipocyte lineage determination. 33 Interestingly, four SMAD-binding elements (SBEs) were found in the promoter of miR-181d gene. Thus, luciferase assay was performed to evaluate the impact of BMP4 on the SBEs activity of miR-181d promoter. The data suggested that the luciferase activity of wild-type miR-181d promoter was activated by BMP4, while luciferase activity of miR-181d promoter with SBE-deficient was unchanged (Figure 6i ). These results indicated that BMP4-regulated miR-181d targeted Adamts1 during adipogenesis.
MiR-181d regulates Adamts1-ECM-FAK-ERK axis during BMP4-induced adipocyte lineage commitment. To demonstrate the effect of miR-181d on Adamts1 regulation, both retrovirus-miR-181d and specific inhibitor were used to verify the miR-181d function. As expected, overexpression of miR-181d in C3H10T1/2 cells resulted in reduced Adamts1 expression (Figure 7a ; Supplementary Figure S7A and B). In addition, adipogenesis was also promoted by overexpression of miR-181d, but were impaired by Adamts1 co-overexpression (Figures 7a-c; Supplementary Figure S7C and D) . Conversely, miR-181d inhibitor could increase the endogenous level of Adamts1 and impair adipogenesis, while Adamts1 silencing could rescue these effects (Figures 7d-f; Supplementary  Figure S7E -G). These results revealed that miR-181d promotes adipogenesis by downregulating Adamts1. As a mediate of Adamts1's function, ECM proteins and FAK-ERK pathway have also been assessed in miR-181d-Adamts1 axis. Accordingly, miR-181d overexpression increased the expression of Thbs1, Fibronectin, Col1α1, and Col5α1, while cooverexpression of Adamts1 reversed this pattern (Figure 7g) . Afterwards, overexpression of miR-181d weakened FAK-ERK but not p38/Smad signaling pathway (Figure 7h ). What's more, co-overexpression of Adamts1 reversed this effect (Figures 7g  and h ). Correspondingly, miR-181d inhibitor reduced ECM protein level followed by activating the phosphorylation of FAK-ERK but not p38/Smad signaling pathway, while Adamts1 silencing reversed this pattern (Figures 7i and j) . Therefore, our results indicated that miR-181d promotes adipogenesis via targeting Adamts1 followed by activation of ECM-FAK-ERK pathway.
Discussion
In adipose tissues, mature adipocytes and their progenitor cells (preadipocytes) exist within an environment rich in ECM proteins. 4, 10, 38 The function of adipose tissue is regulated by physiological interactions between cells and ECM miR-181d-regulated Adamts1 impairs adipogenesis S-Z Chen et al proteins. 4, 39, 40 Adipocyte differentiation requires space expansion, which stems from ECM remodeling. 4 ,38 ECM remodeling is regulated by a variety of modifiers, together with their respective enhancers and inhibitors. The Adamts proteins have been shown to contribute to proteolytic processes in the ECM, with Adamts1, the first identified Adamts family member, able to cleave proteoglycan, aggrecan,collagen,elastin, and other ECM proteins. 16, 17, 19 The results of the present study demonstrate that Adamts1 is crucial for adipose tissue development, and in C57BL/6J mice maintained on chow or HFD were injected subcutaneously adjacent to both inguinal fat pad sites with adeno-Adamts1 shRNA, while controls were injected with adeno-LacZ shRNA. (g) Body weight gain trends for injected mice (n = 5). (h) Fasting blood glucose (FBG) and random blood glucose (RBG) (n = 5) in mice. Glucose concentrations during an insulin tolerance test (n = 5) (i) or an i.p. glucose tolerance test (n = 5) (j). (k) Plasma total cholesterol and low-density lipoprotein-cholesterol (LDL-C) of injected mice Figure 6 Adamts1 is targeted by miR-181d. (a) Schematic representation of miR-181d and Adamts1 3ʹ-UTR. The seed sequence is underlined and the fonts with gray background indicate the nucleotides mutated in the Adamts1 3ʹ-UTR. (b) Luciferase activity was determined using luminometry. 293T cells were transfected with 10 ng of mock psiCHECK2, psiCHECK2-Adamts1 3ʹ-UTR-WT, or psiCHECK2-Adamts1 3ʹ-UTR-Mut vector, plus 30 nM miR-181d mimic or a negative control mimic. Firefly and Renilla luciferase activities were measured in cell lysates, and values were normalized to the psiCHECK2 vector. Results are presented as fold change. (c and d) Linear regression analysis between ADAMTS1 and miR-181d expression levels in human subcutaneous adipose tissues (n = 30) and visceral adipose tissues (n = 30). (e-g) The miR-181d expression in iWAT and eWAT from HFD (n = 6), ob/ob (n = 6), and BMP4 transgenic (n = 6) mice were detected using qRT-PCR. (h) qRT-PCR was performed to detect miR-181d expression in C3H10T1/2 cells on day 0. (i) Luciferase activity was determined using luminometry. 293T cells were transfected with 200 ng of mock psiCHECK2, psiCHECK2-miR-181d promoter-SBE-WT, or psiCHECK2-miR-181d promoter-SBE-MUT vector, plus 20 ng/ml BMP4 or control. Firefly and Renilla luciferase activities were measured in cell lysates, and values were normalized to the psiCHECK2 vector. Results are presented as fold change. Data are presented as the mean ± S.E.M. *Po0.05, **Po0.01, ***Po0.001 (Figure 2 ). In vivo, specific ablation of Adamts1 in iWAT enlarged the adipose mass and increased body weight ( Figure 5 ). These results contradict previous reports that Adamts1
− / − mice display stunted growth and exhibit exceptionally lean bodies, together with a significantly reduced eWAT volume. 28 However, as Adamts1 is expressed in a number of tissues (Figure 1) , it cannot be excluded that the change of fat in systemic knockout of Adamts1 may be caused by change in other tissues. However, in our model, selective disruption of Adamts1 resulted in iWAT fat pad enlargement, which provides more direct evidence between Adamts1 and adipose tissue. Surprisingly, Adamts1 disruption in iWAT impaired insulin sensitivity and plasma lipid homeostasis, indicating that Adamts1 involves in not only obesity but also obesity-related metabolic syndrome.
It is well established that adipocytes are enmeshed in a dense network of ECM. 4, 38 The ECM components in adipose tissue are known to be regulated by matrix metalloproteinases and thereby enabled remodeling. 41 Thus, a concrete understanding of the biological functions of Adamts1, which can degrade varieties of substrates, will likely involve insights derived from identifying its substrates and regulation of its catalytic function. A point mutation within the Adamts1 zincbinding motif eliminated its capacity to inhibit adipogenesis and to induce ECM remodeling (Figure 3 ), suggesting that Adamts1 catalytic function is critical in this process. The ECM contains many different proteins, such as Thbs1, Fibronectin, and collagens. During obesity, ECM protein expression is modified in WAT. In this study, we revealed that forced expression of Adamts1 nearly eliminates Thbs1 and Fibronectin expression. In addition, Adamts1 also catalyzes the degradation of typical fibril-forming collagens such as Col1α1 and Col5α1, which have been defined as a 'high-iWAT expression type'. 10 Moreover, the expression level of these ECM proteins were positively correlated with obesity, which further support a functional role of Adamts1 during adipogenesis (Supplementary Figure S3) . It should be noted that the regulation of ECM is a complex systematic process involving a large number of molecules. Herein, we only concentrated on the regulation of Thbs1, Fibronectin and collagens during adipogenesis. However, other molecule like SPARC, which functions as an inhibitor of adipogenesis, 42, 43 may also serve as a substrate of Adamts1 during adipocyte lineage commitment. Altogether, we propose that Adamts1 impairs adipocyte lineage commitment by influencing the cell microenvironment through degrading ECM components rather than regulating a single target or substrate.
The commitment of multipotent mesenchymal cells to various lineage types is determined by cytokine/growth factor stimuli and mechanical stresses transmitted by cell interactions with various ECM components that provide a structure for peripheral cells. 34, 38 ECM changes initiate integrin signaling, altering intracellular microtubule and actin cytoskeletons and subsequently a cascade of downstream chemical events, 44 depending on the density of exposed integrinbinding sites. 34 Besides, cytoskeleton reorganization ultimately dictates the fate of multipotent mesenchymal cells. 45 Engagement of integrin α1β1 and α2β1 binding sites strongly activates ERK and impairs adipogenesis, while the engagement of αvβ3 binding sites strongly activates p38 kinase, which suppresses ERK in MSCs. 34 We have previously shown that p38/Smad signaling is required for adipocyte lineage commitment. 33 However, Adamts1 had no obvious influence on p38/Smad in this study (Figure 4 ). In contrast, Adamts1 increased ERK1/2 phosphorylation during BMP4-mediated commitment of C3H10T1/2 cells, which agrees with other evidence that ERK acitvity is attenuated by BMP4 in embryonic stem cells. 46 Therefore, our findings suggest that Adamts1-induced microenvironment changes trigger the downstream ERK1/2 pathway. We then sought to answer the question why a metalloprotease-mediated ECM remodeling can affect the phosphorylation level ERK1/2. FAK locates closely with surface integrin receptors, which serve as a junction between cell and ECM. 36 The integrin engagement with ECM remodeling increased FAK tyrosine phosphorylation, which leads to activation of ERK1/2. 35, 36 Indeed, our data verified that FAK signaling pathways provide a link between the activation of ERK1/2 and ECM remodeling during the adipocyte lineage commitment. Overall, FAK-activated ERK1/2 signaling pathway is responsible for Adamts1-mediated impairment of BMP4-induced adipocyte lineage commitment.
The miR-181 family were highly enriched in eWAT and reported to be important for the development and production of the pro-inflammatory B and T cells. 47, 48 The TLR/NFκB-related miR-181a decreased in monocytes of obese individuals and is a putative biomarker of metabolic syndrome. 49 Moreover, miR-181a could promote adipogenesis via targeting TNFα, 50 and downregulation of miR-181a could improve hepatic insulin sensitivity by upregulating sirtuin-1. 51 In this study, miR-181d was predicted to be a putative regulator of Adamts1. Interestingly, miR-181d has been reported to have a general role in regulating lipid content of hepatocytes via targeting Adamts5, which functions similarly with Adamts1. 52 Besides, miR-181d shares the same seed sequence with miR-181a, in view of which we supposed that miR-181d might participate in adipogenesis by targeting Adamts1. Our data confirmed that miR-181d promotes adipocyte lineage commitment by regulating Adamts1-ECM-FAK-ERK axis. Thus, we put forward for the first time that miR-181d is involved in adipogenesis and that its expression is strongly correlated with obesity.
In summary, this study has identified Adamts1 as a target of miR-181d that negatively regulates adipogenesis by impairing BMP4-induced adipocyte lineage commitment. The critical role of Adamts1 in this process is mediated through ECM remodeling that requires Adamts1 catalytic activity and followed by activating FAK-ERK1/2 pathway. These results provide new evidence regarding the role of Adamts1 in obesity and advance our understanding of the mechanistic regulation of adipocyte lineage commitment (Figure 8 ). Animal study. Adipose tissue-specific BMP4 transgenic mice were generated as described before. 32 To build a mouse model of obesity, C57BL/6J mice were fed with HFD (51% kcal in fat, beginning at age 6 weeks) for 2.5 months and mice fed miR-181d-regulated Adamts1 impairs adipogenesis S-Z Chen et al with normal chow diet were used as controls. All studies involving animal experimentation were approved by the Animal Experimental Ethics Committee of Shanghai Medical College, Fudan University, and followed the National Institute of Health guidelines on the care and use of animals.
Isolation of adipocytes and SVF from whole adipose tissue. Adipocyte and SVF were isolated from adipose tissue of HFD and chow-fed C57BL/ 6J mice. Briefly, the adipose tissue was digested with an equal volume of collagenase type VIII (Sigma-Aldrich, St. Louis, MO, USA) containing 1% BSA for 1 h at 37°C with shaking. Following complete digestion, the adipocytes were separated from the SVF by centrifugation at 1500 × g for 5 min. The floating adipocytes were transferred to a fresh tube, and the precipitated material containing SVF was resuspended with ammonium chloride lysis buffer to remove red blood cells.
Plasmids and viral vectors. Full-length mouse complementary DNA sequence for Adamts1 was amplified and subsequently cloned into the pMSCVpuro retroviral vector (Stratagene, Santa Clara, CA, USA). Likewise, the mmumiR-181d precursor sequence was amplified from the mouse genome sequence and then cloned into pMSCV-puro retroviral vector. Two fragments of the Adamts1 3ʹ-UTR, each containing a putative binding site or mutated site for miR-181d, were respectively cloned between the XhoI (5ʹ-end) and NotI (3ʹ-end) restriction sites downstream of a Renilla luciferase reporter, and then cloned into the psiCHECK2 dual-luciferase reporter vector (Promega, Madison, WI, USA) downstream of the Renilla luciferase reporter gene using the primers available in Supplementary Information.
Cells culture and induction of adipocyte lineage commitment/ differentiation. C3H10T1/2 MSCs were propagated and differentiated as described previously.
31 C3H10T1/2 cells were cultured in DMEM (GIBCO-BRL) supplemented with 450 mg/dl glucose and 10% calf serum (PAA) and maintained at 37°C in a 10% CO 2 environment. Initially, cells were seeded at a low density and allowed to grow until the following day when they were 20-30% confluent. The cells were then treated with or without BMP4 (R&D Systems, Minneapolis, MN, USA) for another 6 days in order to induce adipocyte lineage commitment. After establishing of cell commitment, the cells were then induced to differentiate in DMEM containing 10% fetal bovine serum (FBS), 1 μg/ml insulin (I), 1 μM dexamethasone (D), and 0.5 mM 3-isobutyl-1-methylxanthine (M) for 2 days; followed by incubation in DMEM containing 10% FBS and 1 μg/ml insulin for another 2 days. Cells were finally cultured in DMEM with 10% FBS.
RNA interference. Stealth siRNA duplexes specific to Adamts1 were designed and synthesized by Invitrogen (Carlsbad, CA, USA). The silencing effects of several siRNA duplexes were screened and tested initially by Western blot to confirm their ability to knockdown target gene expression. Stealth siRNA Negative Control Duplexes with a similar GC content were used as a control. C3H10T1/2 stem cells were transfected at 30-50% confluence with siRNA duplexes using Lipofectamine RNAi MAX (Invitrogen) according to the manufacturer's instructions.
Western blot analyses. Adipose tissue and cultured cells were scraped into lysis buffer containing 50 mM Tris-HCl (pH 6.8), 2% SDS, phosphatase inhibitors (10 mM Na 3 VO 4 , 10 mM NaF), and a protease inhibitor cocktail (Roche, Mannheim, Germany). Equal amounts of protein were subjected to SDS/PAGE and immunoblotted with specific primary antibodies against one of the following targets: Adamts1 (Millipore, Billerica, MA, USA); Hsp90, PPARγ, or C/EBPα, (Santa Cruz, CA, USA); 422/aP2 (prepared in Dr. Lane's lab); p38 MAPK kinase, phospho-p38, Smad1, phospho-Smad1/5/8, FAK, phospho-FAK, ERK1/2, and phospho-ERK1/2 (Cell Signaling Technology, Danvers, MA, USA); Pref1 (Proteintech Group, Chicago, IL, USA); Col5α1 (ABclonal, Cambridge, MA, USA); Thbs1 (Novus, Littleton, CO, USA); Fibronectin (BD, Franklin Lakes, NJ, USA); Col1α1 and β-actin (Sigma-Aldrich).
Quantitative RT-PCR analysis. Total RNA was harvested from cells or mouse adipose tissue using TRIzol reagent (Invitrogen). First strand cDNA synthesis was performed using the PrimeScript RT Master Mix (Takara Bio, Otsu, Japan) and random primers. Real-time quantitative PCR reactions were performed on an Applied Biosystems 7500 or 7900 Real-Time PCR System using the 2 × Power SYBR Green PCR Master Mix (Applied Biosystems, Carlsbad, CA, USA). The threshold cycles (Ct) for the target genes and the 18S rRNA were determined in triplicate experiments, and the relative RNA quantity was calculated using the comparative Ct method. qRT-PCR primers were available in Supplementary Information.
MiRNAs were reverse-transcribed using the TaqMan miRNA reverse transcription kit (Applied Biosystems) and miRNA-specific primers (Applied Biosystems). MiRNA expression levels were then analyzed using the TaqMan MicroRNA assay (Applied Biosystems) according to the manufacturer's instructions. Quantitation of a ubiquitously expressed miRNA (U6) was performed as an endogenous control.
Oil red O staining. Cells were washed three times with PBS and then fixed for 15 min with 3.7% formaldehyde. Oil Red O (0.5% in isopropanol) was diluted with water (3 : 2), filtered through a 0.45 μm filter, and then incubated with the fixed cells for 1 h at room temperature. Cells were then washed with water and the stained lipid droplets in the adipocytes were visualized by light microscopy and photographed.
Luciferase assay. 293T cells were plated in reduced serum and antibiotic-free Opti-MEM I and 24 h later were transfected with 10 ng of psiCHECK2-Adamts1 3ʹ-UTR vector and psiCHECK2-mutant Adamts1 3ʹ-UTR vector 24 h using Lipofectamine2000. Cells were co-transfected with either a miR-181d mimic or a negative control (Applied Biosystems) at 100 nM. After incubation for 48 h, Firefly and Renilla luciferases were measured in cell lysates using the Dual-Luciferase Reporter Assay System (Promega). Firefly luciferase activity was used for normalization and as an internal control for transfection efficiency.
H&E staining and cell size quantification. Standard H&E staining was performed on 5 μm thick paraffin sections of inguinal adipose tissue. Cell diameter was measured in the H&E-stained sections from 5 individual samples per group using Image J (National Institutes of Health, Bethesda, MD, USA).
Glucose and insulin tolerance tests. For glucose tolerance, mice were injected i.p. with D-glucose (2 mg/g body weight) after an overnight fast, and tail blood glucose levels were monitored. For insulin tolerance, mice fed ad libitum were injected i.p. with human insulin (Eli Lilly; 0.75 mU/g body weight) after a 4 h fast, and tail blood glucose levels were monitored.
Measurements of blood parameters. Mice blood samples were collected by retroorbital bleeding methods. Sera were prepared and used for measurements. Total cholesterol and LDL-C levels were determined using the Roche Cobas C311 chemistry analyzer. Figure 8 Model of Adamts1-mediated impairment of MSCs adipocyte commitment. Adipogenesis is a bi-phasic process: lineage commitment into preadipocytes, and terminal differentiation into mature adipocytes. Adamts1 is predominantly implicated in adipocyte lineage commitment and contributes to the development of obesity. Adamts1 impairs adipocyte lineage commitment through ECM remodeling following by activating FAK-ERK signaling pathway. Additionally, miR-181d, upregulated by BMP4, dominated Adamts1-ECM-FAK-ERK axis during adipocyte lineage commitment miR-181d-regulated Adamts1 impairs adipogenesis S-Z Chen et al Adenoviral expression vectors and infection. The adenoviral expression vector pBlock-it (Invitrogen) encoding shRNA against the Adamts1 gene was constructed according to the manufacturer's protocols. The Adamts1 shRNA sequence was 5ʹ-GCCAGCAGCTACATCTGAAGT-3ʹ, and the LacZ shRNA sequence was 5ʹ-AATTTAACCGCCAGTCAGGCT-3ʹ. Adenovirus was amplified and purified using Sartorius Adenovirus Purification Kits (Sartorius, Goettingen, Germany). Adenovirus solution was injected subcutaneously adjacent to the mouse inguinal fat pad twice weekly for 4 weeks beginning at 6 weeks of age.
Statistical analyses. A non-paired Student t-tests were used for data analyses, and paired t-tests were used to compare adeno-LacZ shRNA baseline and adenoAdamts1 shRNA results in the same experimental mouse. Pearson's correlation analysis was used to describe the linear association between variables. The distributions of the variables of interest were examined using quantile-quantile plots. When the data were non-normally distributed, natural logarithm transformations were used to attain approximate normality before analysis. All data from samples were expressed as the mean ± S.E.M. Po0.05 was regarded as statistically significant.
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